Overview

The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy

Status:
Unknown status
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
FP-10 is a food ingredient derived from milk casein. FP-10 can inhibit H. pylori to attach to the gastric epithelium. FP-10 has been made clear to decrease the intragastric urease activity (which is assumed to be produced by H. pylori) measured by the urea breath test. FP-10 can also detach H. pylori from gastric epithelium. We have hypothesized that FP-10 increases the eradication rates by a triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hamamatsu University
Collaborator:
Oita University
Treatments:
Amoxicillin
Clarithromycin
Dexlansoprazole
Lansoprazole